|
|
Blood, 1 September 2004, Vol. 104, No. 5, pp. 1419-1427.
Prepublished online as a Blood First Edition Paper on May 20, 2004; DOI 10.1182/blood-2004-01-0201.
Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
A dose effect of IL-7 on thymocyte development
Nahed El Kassar,
Philip J. Lucas,
David B. Klug,
Monica Zamisch,
Melinda Merchant,
Catherine V. Bare,
Baishakhi Choudhury,
Susan O. Sharrow,
Ellen Richie,
Crystal L. Mackall, and
Ronald E. Gress
From the Experimental Immunology Branch and the Pediatric Oncology Branch, National Cancer Institute (NCI), Bethesda, MD; and the University of Texas, M. D. Anderson Cancer Center, Department of Carcinogenesis, Smithville, TX.
To study interleukin-7 (IL-7) in early thymocyte development, we generated mice transgenic (Tg) for the IL-7 gene under control of the lck proximal promoter. Founder line TgA, with the lowest level of IL-7 overexpression, showed enhanced  T-cell development. In contrast, in the highest overexpressing founder line, TgB,  T-cell development was disturbed with a block at the earliest intrathymic precursor stage. This was due to decreased progenitor proliferation as assessed by Ki-67 staining and in vivo bromodeoxyuridine (BrdU) incorporation. Bcl-2 was up-regulated in T-cellcommitted progenitors in all Tg lines, and accounted for greater numbers of double positive (DP), CD4 single positive (SP), and CD8SP thymocytes in TgA mice where, in contrast to TgB mice, thymocyte progenitor proliferation was normal. Mixed marrow chimeras using TgB+ and congenic mice as donors, and experiments using antiIL-7 monoclonal antibody (MAb) in vivo, confirmed the role of IL-7 protein in the observed TgB phenotype. In conclusion, at low Tg overexpression, IL-7 enhanced  T-cell development by increasing thymocyte progenitor survival, while at high overexpression IL-7 reduces their proliferation, inducing a dramatic block in DP production. These results show for the first time in vivo a dose effect of IL-7 on  T-cell development and have implications for IL-7 in the clinical setting.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Bessette, M. L. Lang, R. A. Fava, M. Grundy, J. Heinen, L. Horne, R. Spolski, A. Al-Shami, H. C. Morse III, W. J. Leonard, et al.
A Stat5b transgene is capable of inducing CD8+ lymphoblastic lymphoma in the absence of normal TCR/MHC signaling
Blood,
January 1, 2008;
111(1):
344 - 350.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bruinsma, P. L. van Soest, P. J. M. Leenen, B. N. Lambrecht, T. Cupedo, B. Lowenberg, J. J. Cornelissen, and E. Braakman
Keratinocyte Growth Factor Induces Expansion of Murine Peripheral CD4+Foxp3+ Regulatory T Cells and Increases Their Thymic Output
J. Immunol.,
December 1, 2007;
179(11):
7424 - 7430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Clise-Dwyer, G. E. Huston, A. L. Buck, D. K. Duso, and S. L. Swain
Environmental and Intrinsic Factors Lead to Antigen Unresponsiveness in CD4+ Recent Thymic Emigrants from Aged Mice
J. Immunol.,
February 1, 2007;
178(3):
1321 - 1331.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Swainson, S. Kinet, C. Mongellaz, M. Sourisseau, T. Henriques, and N. Taylor
IL-7-induced proliferation of recent thymic emigrants requires activation of the PI3K pathway
Blood,
February 1, 2007;
109(3):
1034 - 1042.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Swainson, E. Verhoeyen, F.-L. Cosset, and N. Taylor
IL-7R{alpha} Gene Expression Is Inversely Correlated with Cell Cycle Progression in IL-7-Stimulated T Lymphocytes.
J. Immunol.,
June 1, 2006;
176(11):
6702 - 6708.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Henson, R. Snelgrove, T. Hussell, D. J. Wells, and R. Aspinall
An IL-7 Fusion Protein That Shows Increased Thymopoietic Ability
J. Immunol.,
September 15, 2005;
175(6):
4112 - 4118.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Fry and C. L. Mackall
The Many Faces of IL-7: From Lymphopoiesis to Peripheral T Cell Maintenance
J. Immunol.,
June 1, 2005;
174(11):
6571 - 6576.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. D. Shultz, B. L. Lyons, L. M. Burzenski, B. Gott, X. Chen, S. Chaleff, M. Kotb, S. D. Gillies, M. King, J. Mangada, et al.
Human Lymphoid and Myeloid Cell Development in NOD/LtSz-scid IL2R{gamma}null Mice Engrafted with Mobilized Human Hemopoietic Stem Cells
J. Immunol.,
May 15, 2005;
174(10):
6477 - 6489.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zamisch, B. Moore-Scott, D.-m. Su, P. J. Lucas, N. Manley, and E. R. Richie
Ontogeny and Regulation of IL-7-Expressing Thymic Epithelial Cells
J. Immunol.,
January 1, 2005;
174(1):
60 - 67.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Munitic, J. A. Williams, Y. Yang, B. Dong, P. J. Lucas, N. El Kassar, R. E. Gress, and J. D. Ashwell
Dynamic regulation of IL-7 receptor expression is required for normal thymopoiesis
Blood,
December 15, 2004;
104(13):
4165 - 4172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Yu, B. Erman, J.-H. Park, L. Feigenbaum, and A. Singer
IL-7 Receptor Signals Inhibit Expression of Transcription Factors TCF-1, LEF-1, and ROR{gamma}t: Impact on Thymocyte Development
J. Exp. Med.,
September 20, 2004;
200(6):
797 - 803.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|